Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 ...

CellFE®, a disruptive life sciences company marketing non-viral, non-electroporative cell therapy manufacturing tools, today announced several strategic system placements with major pharmaceutical and ...

In September, Rakovina initiated a collaboration with Variational AI to use their Enki™ platform to discover novel kinase ...

The global market for Artificial Intelligence For Drug Development and Discovery Market has witnessed rapid growth, escalating from a valuation of $520 million in 2019 to a projected $4,815 million by ...

Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom ...

Overview of the Canadian healthcare industry The healthcare industry in Canada is diverse and multifaceted. Unlike the U.S., ...

Exeltis will be granted an exclusive license to market and distribute Theranexus' novel formulation TX01 for the treatment of two rare neurological diseases notably in Europe.Theranexus will be ...

Mr. Jordan succeeds Peter Donato, who served as Zomedica's Chief Financial Officer from March 2023 until August 2024 when he departed to pursue other interests.

LYON, FRANCE / ACCESSWIRE / December 17, 2024 / Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases (the "Company"), today presents an update of its cash ...

ICON plc, a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME Magazine's 2024 list of World's Best ...

Industry-First Capabilities Combined: Medera's Novoheart has a unique human-based mini-Heart technology platform for disease ...

In this business technologies interview features, Discover how AI is revolutionizing cloud agility and software testing in ...